A nurse is caring for a client diagnosed with preeclampsia and is being treated with magnesium sulfate IV. The client's respiratory rate is 10/min and deep-tendon reflexes are absent. Which of the following actions should the nurse take?

Explanation:

A. Acarbose:

Acarbose is an oral antidiabetic medication that works by slowing down the digestion and absorption of carbohydrates in the intestines. It is typically used in the management of type 2 diabetes but is not commonly prescribed for gestational diabetes mellitus (GDM). Acarbose is not usually recommended during pregnancy, especially since there are other safer options available for managing GDM.

B. Repaglinide:

Repaglinide is another oral antidiabetic medication that stimulates insulin release from the pancreas. While it is effective in lowering blood sugar levels, it is not commonly used as a first-line treatment for gestational diabetes. Repaglinide may have a more rapid onset of action compared to other oral antidiabetic drugs, but its use during pregnancy is not as common as other medications like glyburide or insulin.

C. Glipizide:

Glipizide is an oral sulfonylurea medication used primarily in the management of type 2 diabetes. It stimulates insulin secretion from the pancreas. However, like other sulfonylureas, glipizide is not typically recommended for use during pregnancy due to safety concerns for the developing fetus. It may also have a higher risk of hypoglycemia compared to other options.

D. Glyburide:

Glyburide is an oral sulfonylurea medication that helps lower blood sugar levels by stimulating insulin release from the pancreas. It is one of the commonly used medications for managing gestational diabetes when diet and exercise alone are not sufficient. Glyburide is generally considered safe for use during pregnancy, especially after the first trimester, and it has been found to effectively control blood glucose levels in many pregnant individuals with GDM.

Explanation:

A. Gradual lordosis:

Gradual lordosis refers to an increased curvature of the lower spine (lumbar region). During pregnancy, as the uterus enlarges and the center of gravity shifts forward, the body compensates by increasing the curve of the lower spine. This change helps maintain balance and stability as the woman's abdomen expands due to the growing fetus. It is considered a normal adaptation to pregnancy and is often observed in the third trimester.

B. Decreased mobility of pelvic joints:

This statement is incorrect in the context of pregnancy. In fact, during pregnancy, the hormone relaxin is released, which causes relaxation and increased mobility of pelvic joints. This increased mobility is important for allowing the pelvis to expand during childbirth, facilitating the passage of the baby through the birth canal. Therefore, decreased mobility of pelvic joints is not an expected physiologic change during pregnancy.

C. Posterior neck flexion:

Posterior neck flexion refers to bending the neck backward. This is not typically associated with pregnancy-related changes. Pregnancy-related changes mainly affect the abdominal area, lower back, and pelvis rather than the neck. Therefore, posterior neck flexion is not an expected physiologic change during pregnancy.

D. Increased abdominal muscle tone:

During pregnancy, the abdominal muscles often experience stretching and relaxation rather than increased tone. This is because the growing uterus and fetus require more space, leading to abdominal wall stretching. The abdominal muscles may become less toned and more relaxed to accommodate the expanding uterus. Therefore, increased abdominal muscle tone is not an expected physiologic change during pregnancy.